Aurobindo Pharma shares in focus after Q3 revenue beat; Europe drives performance

Growth during the quarter was driven by strong performance in Europe, where revenues climbed 27% YoY. The US business also came in better than analyst estimates.

Leave a Reply

Your email address will not be published. Required fields are marked *